Chandra M Goparaju

Title: Chandra M Goparaju: Innovator in Lung Cancer Treatment

Introduction

Chandra M Goparaju is a notable inventor based in Cliffside, NJ (US). She has made significant contributions to the field of oncology, particularly in the diagnosis and treatment of non-small cell lung cancer (NSCLC). Her innovative approach focuses on the use of circulating interleukin-18 as a biomarker for improving patient outcomes.

Latest Patents

Chandra holds a patent titled "Use of circulating interleukin-18 for prognosticating and treating recurrence in early stage non-small cell lung cancer." This patent outlines methods for aiding in the diagnosis and treatment of NSCLC adenocarcinoma. The methods involve determining elevated circulating Interleukin-18 (IL-18) values to assist in the diagnosis and treatment of NSCLC. Medical interventions based on determining circulating IL-18 levels include additional scanning, surgical resection of tumors, and administration of adjuvant therapy, such as chemotherapy or immune therapy. She has 1 patent to her name.

Career Highlights

Chandra is affiliated with New York University, where she continues her research and development in cancer treatment. Her work has been instrumental in advancing the understanding of biomarkers in oncology.

Collaborations

Chandra collaborates with esteemed colleagues in her field, including Harvey I Pass, who is also recognized for his contributions to lung cancer research.

Conclusion

Chandra M Goparaju's innovative work in the use of interleukin-18 for lung cancer treatment exemplifies her commitment to improving patient care and outcomes. Her contributions to the field are invaluable and continue to inspire future research in oncology.